Dimethyl fumarate treatment of relapsing-remitting multiple sclerosis influences B-cell subsets

OBJECTIVE: To test the hypothesis that dimethyl fumarate (Tecfidera, BG-12) affects B-cell subsets in patients with relapsing-remitting multiple sclerosis (RRMS). METHODS: Peripheral blood B cells were compared for surface marker expression in patients with RRMS prior to initiation of treatment, aft...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neurol Neuroimmunol Neuroinflamm
Hlavní autoři: Lundy, Steven K., Wu, Qi, Wang, Qin, Dowling, Catherine A., Taitano, Sophina H., Mao, Guangmei, Mao-Draayer, Yang
Médium: Artigo
Jazyk:Inglês
Vydáno: Lippincott Williams & Wilkins 2016
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4784801/
https://ncbi.nlm.nih.gov/pubmed/27006972
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000211
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky